Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-03

Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating stereotactic body radiotherapy for spinal and paraspinal metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Spinal Metastases | Phase 2 | Status: COMPLETED